Literature DB >> 7522194

Integrins as dynamic regulators of vascular function.

F W Luscinskas1, J Lawler.   

Abstract

The vascular endothelium lines the entire cardiovascular system and serves as a nonthrombogenic and selectively permeable boundary between the blood-stream and extravascular space. Endothelial cells are polar cells that are continuously subjected to fluid-generated forces on their luminal surface whereas their abluminal surface resides on basement membranes/extracellular matrix. The integrin family of cell-surface heterodimeric glycoproteins is located along both of these surfaces and participates in maintaining the normal endothelium and in the dynamic changes associated with the pathophysiology of the endothelium. Endothelial cell beta 1 and beta 3 integrins function together with other families of adhesion molecules during vasculogenesis, angiogenesis, inflammation, and wound healing. Leukocyte beta 1 and beta 2 integrins, in conjunction with members of the Ig and selectin gene families expressed on endothelium, mediate leukocyte recruitment to sites of inflammation. The structural and functional properties of integrins make them uniquely suited to mediate these essential and complex processes in the vasculature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522194     DOI: 10.1096/fasebj.8.12.7522194

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  56 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

2.  Type IV collagen modulates angiogenesis and neovessel survival in the rat aorta model.

Authors:  E Bonanno; M Iurlaro; J A Madri; R F Nicosia
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

3.  Integrin binding to fibronectin and vitronectin maintains the barrier function of isolated porcine coronary venules.

Authors:  M H Wu; E Ustinova; H J Granger
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

4.  The cell and molecular biological approach to biomaterial research: a perspective.

Authors:  C J Kirkpatrick; M Wagner; H Köhler; F Bittinger; M Otto; C L Klein
Journal:  J Mater Sci Mater Med       Date:  1997-03       Impact factor: 3.896

Review 5.  Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules.

Authors:  Guochang Hu; Aaron T Place; Richard D Minshall
Journal:  Chem Biol Interact       Date:  2007-08-15       Impact factor: 5.192

6.  Topology of the heterogeneous nature of the extracellular matrix on stochastic modeling of tumor-induced angiogenesis.

Authors:  Franck Amyot; Alex Small; Hacène Boukari; Kevin Camphausen; Amir Gandjbakhche
Journal:  Microvasc Res       Date:  2007-11-22       Impact factor: 3.514

7.  Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells.

Authors:  Stephan Grabbe; Georg Varga; Stefan Beissert; Meike Steinert; Gunther Pendl; Stephan Seeliger; Wilhelm Bloch; Thorsten Peters; Thomas Schwarz; Cord Sunderkötter; Karin Scharffetter-Kochanek
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  Selectively targeting T- and B-cell lymphomas: a benzothiazole antagonist of alpha4beta1 integrin.

Authors:  Richard D Carpenter; Mirela Andrei; Olulanu H Aina; Edmond Y Lau; Felice C Lightstone; Ruiwu Liu; Kit S Lam; Mark J Kurth
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

Review 9.  Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

Authors:  M P Kim; S I Park; S Kopetz; G E Gallick
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

10.  Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification.

Authors:  Chad Tang; Faina Kligman; Coby C Larsen; Kandice Kottke-Marchant; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2009-02       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.